Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Cortés Castan, Javier

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Schettini, Francesco
dc.contributor.author	Giuliano, Mario
dc.contributor.author	Lambertini, Matteo
dc.contributor.author	Bartsch, Rupert
dc.contributor.author	Pinato, David James
dc.contributor.author	Onesti, Concetta Elisa
dc.contributor.author	Cortés Castan, Javier
dc.date.accessioned	2022-03-15T12:24:22Z
dc.date.available	2022-03-15T12:24:22Z
dc.date.issued	2021-09
dc.identifier.citation	Schettini F, Giuliano M, Lambertini M, Bartsch R, Pinato DJ, Onesti CE, et al. Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer. Cancers. 2021 Sep;13(17):4421.
dc.identifier.issn	2072-6694
dc.identifier.uri	https://hdl.handle.net/11351/7184
dc.description	Antraciclines; Càncer de mama; Receptor hormonal
dc.description.sponsorship	This study was supported by Mednote, spin-off—University of Trieste, within the Mozart Program.
dc.language.iso	eng
dc.publisher	MDPI
dc.relation.ispartofseries	Cancers;13(17)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Mama - Càncer - Tractament
dc.subject	Quimioteràpia combinada
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.subject.mesh	/therapeutic use
dc.title	Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.3390/cancers13174421
dc.subject.decs	neoplasias de la mama
dc.subject.decs	/farmacoterapia
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.subject.decs	/uso terapéutico
dc.relation.publishversion	https://doi.org/10.3390/cancers13174421
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Schettini F] Translational Genomics and Targeted Therapies in Solid Tumors Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. [Giuliano M] Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. [Lambertini M] Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. [Bartsch R] Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria. [Pinato DJ] Division of Cancer, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Department of Translational Medicine, Università del Piemonte Orientale “A. Avogadro”, Novara, Italy. [Onesti CE] Clinical and Oncological Research Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [Cortes J] Oncology Department, IOB Institute of Oncology, Quiron Group, 08023 Madrid, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	34503231
dc.identifier.wos	000694139700001
dc.rights.accessrights	info:eu-repo/semantics/openAccess